Health Sciences Acquisiti... (HSAQ)
NASDAQ: HSAQ
· Real-Time Price · USD
13.31
2.59 (24.16%)
At close: Jan 26, 2023, 9:59 PM
Health Sciences Acquisitions 2 Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 836K | 868K | 140K | 987K | 778K | 419K | 915K | 1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 46K | 44K | 65K | 68K | 44K | 41K | 54K | 44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 790K | 824K | 75K | 919K | 734K | 378K | 861K | 1.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -19.33M | -18.92M | -26.77M | -16.34M | -16.86M | -14.52M | -12.96M | -10.05M | -389.69K | -813.41K | -938.17K | -451.95K | -92.05K | -94.44K | -96.32K | -111.95K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 127.62K | 203.25K | 14.27K | 4.03K | 4.03K | 3.99K | 3.95K |
Pretax Income | -19.36M | -18.75M | -24.72M | -15.43M | -15.98M | -13.32M | -12.05M | -10.94M | -876.72K | -685.79K | -734.92K | -437.69K | -196.01K | -90.41K | -92.33K | -108K |
Net Income | -19.36M | -18.75M | -26.21M | -15.43M | -15.98M | -13.32M | -12.05M | -9.45M | -1.36M | -430.54K | -531.67K | -409.16K | -299.98K | -90.41K | -92.33K | -108K |
Selling & General & Admin | 6.26M | 6.26M | 7.86M | 5.67M | 6.47M | 6.34M | 5.32M | 4.41M | 756.72K | 813.41K | 938.17K | 451.95K | 83.99K | 94.44K | 96.32K | 111.95K |
Research & Development | 13.85M | 13.48M | 17.49M | 11.6M | 11.13M | 8.56M | 8.5M | 8.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 20.12M | 19.75M | 25.35M | 17.26M | 17.59M | 14.9M | 13.82M | 12.66M | 756.72K | 813.41K | 938.17K | 451.95K | 83.99K | 94.44K | 96.32K | 111.95K |
Interest Expense | -36K | n/a | -2.74M | n/a | n/a | 915K | 941K | 885K | -141.89K | 127.62K | -203.25K | 14.27K | 103.97K | n/a | n/a | 3.95K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.16M | 19.79M | 25.42M | 17.33M | 17.64M | 14.94M | 13.87M | 12.71M | 756.72K | 813.41K | 938.17K | 451.95K | 83.99K | 94.44K | 96.32K | 111.95K |
Income Tax Expense | n/a | n/a | 1.49M | n/a | n/a | n/a | n/a | -1.49M | 487.03K | -255.25K | -203.25K | -28.53K | 103.97K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 38.39M | 38.24B | 36.82B | 37.62B | 35.8B | 35.24B | 34.61B | 27.64B | 16.43M | 13.72M | 20.45M | 20.45M | 20.45M | 20.45M | 20.45M | 20.45M |
Shares Outstanding (Diluted) | 38.39M | 38.24B | 36.82B | 37.62B | 35.8B | 35.24B | 34.61B | 27.64B | 16.43M | 13.72M | 20.45M | 20.45M | 20.45M | 20.45M | 20.45M | 20.45M |
EPS (Basic) | -0.5 | -0.49 | -1.66 | -0.41 | -0.45 | -0.00 | -0.00 | -0.00 | -0.08 | -0.03 | -0.03 | -0.02 | -0.01 | -0.00 | -0.00 | -0.01 |
EPS (Diluted) | -0.5 | -0.49 | -1.66 | -0.41 | -0.45 | -0.00 | -0.00 | -0.00 | -0.08 | -0.03 | -0.03 | -0.02 | -0.01 | -0.00 | -0.00 | -0.01 |
EBITDA | -19.33M | -18.92M | -26.06M | -16.34M | -16.86M | -14.52M | -12.96M | -11.54M | -876.72K | -558.17K | -734.92K | -423.42K | -196.01K | -90.41K | -92.33K | -104.06K |
EBIT | n/a | n/a | 33.56M | n/a | n/a | -12.4M | -11.11M | -10.05M | -389.69K | -558.17K | -938.17K | -423.42K | -92.05K | -94.44K | -96.32K | -104.06K |
Depreciation & Amortization | n/a | n/a | 1.41M | n/a | n/a | -39.59K | 122.08K | -1.49M | -487.03K | 255.25K | 203.25K | 28.53K | -103.97K | 4.03K | 3.99K | 7.89K |